182 related articles for article (PubMed ID: 6861134)
1. Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
Adams DO; Johnson WJ; Marino PA; Dean JH
Cancer Res; 1983 Aug; 43(8):3633-7. PubMed ID: 6861134
[TBL] [Abstract][Full Text] [Related]
2. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
Schultz RM; Woods WA; Mohr SJ; Chirigos MA
Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
[TBL] [Abstract][Full Text] [Related]
3. Sequential activation of murine mononuclear phagocytes for tumor cytolysis: differential expression of markers by macrophages in the several stages of development.
Johnson WJ; Marino PA; Schreiber RD; Adams DO
J Immunol; 1983 Aug; 131(2):1038-43. PubMed ID: 6306103
[TBL] [Abstract][Full Text] [Related]
4. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
Rao VS; Mitchell MS
J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
[TBL] [Abstract][Full Text] [Related]
5. Expression of a 120,000 dalton protein during tumoricidal activation in murine peritoneal macrophages.
Johnston PA; Somers SD; Hamilton TA
J Immunol; 1987 Apr; 138(8):2739-44. PubMed ID: 3104474
[TBL] [Abstract][Full Text] [Related]
6. Maleic vinyl ether activation of murine macrophages against lung-metastasizing tumors.
Loveless SE; Munson AE
Cancer Res; 1981 Oct; 41(10):3901-6. PubMed ID: 7285000
[TBL] [Abstract][Full Text] [Related]
7. Effect of maleic anhydride-divinyl ether copolymers on experimental M109 metastases and macrophage tumoricidal function.
Pavlidis NA; Schultz RM; Chirigos MA; Luetzeler J
Cancer Treat Rep; 1978 Nov; 62(11):1817-22. PubMed ID: 728899
[TBL] [Abstract][Full Text] [Related]
8. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
[TBL] [Abstract][Full Text] [Related]
9. Macrophage involvement in the protective effect of pyran copolymer against the Madison lung carcinoma (M109).
Schultz RM; Papamatheakis JD; Luetzeler J; Ruiz P; Chirigos MA
Cancer Res; 1977 Feb; 37(2):358-64. PubMed ID: 832262
[TBL] [Abstract][Full Text] [Related]
10. Cellular and serum involvement in protection against Friend leukemia virus.
Schuller GB; Morahan PS
Cancer Res; 1977 Nov; 37(11):4064-9. PubMed ID: 908040
[TBL] [Abstract][Full Text] [Related]
11. Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity.
Puccetti P; Santoni A; Riccardi C; Holden HT; Herberman RB
Int J Cancer; 1979 Dec; 24(6):819-25. PubMed ID: 232496
[TBL] [Abstract][Full Text] [Related]
12. In situ activation of murine peritoneal macrophages by cyclohexyl-1,3-dioxepin and 4-methyl-2-pentenoyl maleic anhydride copolymers.
Kuus K; Ottenbrite RM; Kaplan AM
J Biol Response Mod; 1985 Feb; 4(1):46-59. PubMed ID: 2984339
[TBL] [Abstract][Full Text] [Related]
13. Response of murine leukemia to combined BCNU-maleic anhydride-vinyl ether (MVE) adjuvant therapy and correlation with macrophage activation by MVE in the in vitro growth inhibition assay.
Dean JH; Padarathsingh ML; Keys L
Cancer Treat Rep; 1978 Nov; 62(11):1807-16. PubMed ID: 728898
[No Abstract] [Full Text] [Related]
14. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
Harmel RP; zbar B
J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
[TBL] [Abstract][Full Text] [Related]
15. Pyran copolymer: effect of molecular weight on stem cell mobilization in mice.
Zander AR; Spitzer G; Verma DS; Ginzbarg S; Dicke KA
Biomedicine; 1980 May; 33(3):69-72. PubMed ID: 7448325
[TBL] [Abstract][Full Text] [Related]
16. Macrophage activation by trehalose dimycolate requirement for an expression signal in vitro for antitumoral activity; biochemical markers distinguishing primed and fully activated macrophages.
Grand-Perret T; Lepoivre M; Petit JF; Lemaire G
Eur J Immunol; 1986 Apr; 16(4):332-8. PubMed ID: 3009201
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulation and antitumor effects of MVE-2 in mice.
Talmadge JE; Maluish AE; Collins M; Schneider M; Herberman RB; Oldham RK; Wiltrout RH
J Biol Response Mod; 1984 Dec; 3(6):634-52. PubMed ID: 6334720
[TBL] [Abstract][Full Text] [Related]
18. Characterization of tumor binding by the IC-21 macrophage cell line.
Crawford EK; Latham PS; Shah EM; Hasday JD
Cancer Res; 1990 Aug; 50(15):4578-83. PubMed ID: 2164442
[TBL] [Abstract][Full Text] [Related]
19. Induction of tumor-inhibitory macrophages with a novel synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738).
Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
J Immunol; 1985 Jul; 135(1):679-83. PubMed ID: 3839006
[TBL] [Abstract][Full Text] [Related]
20. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
Marino PA; Adams DO
J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
